Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 066593/0409 | |
| Pages: | 3 |
| | Recorded: | 02/28/2024 | | |
| Attorney Dkt #: | 048517-553N01US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18289261
|
Filing Dt:
|
11/02/2023
|
|
Publication #:
|
|
Pub Dt:
|
09/12/2024
| | | | |
|
Title:
|
ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18289261
|
Filing Dt:
|
11/02/2023
|
|
Publication #:
|
|
Pub Dt:
|
09/12/2024
| | |
PCT #:
|
US2227291
|
|
Title:
|
ANTI-CD73 COMPOUNDS TO TREAT ONCOVIRUS-POSITIVE CANCERS
|
|
|
Assignee
|
|
|
|
|
| 863 MITTEN ROAD, SUITE 102 |
| BURLINGAME, CALIFORNIA 94010 |
|
|
Correspondence name and address
|
| |
LUIS JARAMILLO
|
| |
MINTZ/SAN DIEGO OFFICE
|
| |
ONE FINANCIAL CENTER
|
| |
BOSTON, MA 02111
|
Search Results as of:
09/21/2024 08:30 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
